“If you suffered a loss in Helen of Troy you have until August 3, 2026, to request that the Court appoint you as lead plaintiff.” That was the message from Bronstein, Gewirtz & Grossman, a New York investor-rights firm, when it announced a securities class action against Helen of Troy Limited (NASDAQ: HELE) and certain of its officers.
The suit seeks damages for alleged violations of federal securities laws on behalf of everyone who bought or otherwise acquired Helen of Troy securities between April 24, 2024 and October 8, 2025, both dates included. That is a stretch of about eighteen months. The complaint alleges that throughout the period the defendants made materially false and misleading statements, or failed to disclose key facts.
The firm’s announcement does not spell out those allegations in detail. It points readers to a page on its own site, bgandg.com/HELE, where the full complaint can be reviewed. Investors can also call Peretz Bronstein or his client relations manager, Nathan Miller, at 917-590-0911.
The lead plaintiff role is optional. The firm stressed that an investor’s ability to share in any recovery does not depend on holding it.
Bronstein, Gewirtz & Grossman says it represents investors in class actions on a contingency basis. In practice that means it asks the court to reimburse out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if the case succeeds.
The firm describes itself as nationally recognized in securities fraud class actions and shareholder derivative suits, and says it has recovered hundreds of millions of dollars for investors. Peretz Bronstein, its founding partner, put it this way: “Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”





